期刊文献+

MicroRNA-195与Smad7靶向关系的研究

Investigating the relationship between MicroRNA-195 and Smad7
下载PDF
导出
摘要 目的:构建含有Smad7基因3'-UTR区的荧光素酶报告基因载体,利用双荧光素酶报告基因验证MicroRNA195与其潜在靶基因Smad7的靶向关系。方法:PCR扩增出Smad7基因3'-UTR区片段,以此构建含3'-UTR的荧光素酶报告基因载体(wild type,WT);将miRNA-195与荧光素酶报告重组子共转染至293T细胞中,双荧光素酶报告基因系统检测荧光素酶活性;构建含Smad7基因3'-UTR突变体(mutant,Mut)的荧光素酶报告基因质粒,检测荧光素酶活性变化。结果:测序结果表明,含有Smad7基因3'-UTR区的荧光素酶报告基因载体构建正确;荧光素酶活性实验表明,与对照组相比,miRNA-195可使含Smad7基因3'-UTR区的荧光素酶报告重组子的荧光素酶活性降低40%左右;而定点突变Smad7基因3'-UTR的荧光素酶报告重组子荧光活性未有明显变化。结论:成功构建了Smad7基因3'-UTR区的荧光素酶报告基因载体,而miRNA-195可以直接作用于Smad7基因3'-UTR区,抑制其荧光素酶活性。 Objective: The luciferase reporter vector containing 3’-UTR of Smad7 was constructed. Dual luciferase reporter gene system was applied to determine the association between miRNA-195 and its target gene Smad7. Methods: The 3’-UTR of Smad7 fragment amplified by PCR was cloned into luciferase vector. MiRNA-195 and the luciferase reporters containing 3’-UTR( Smad7-3’ UTR-WT) or mutant 3’-UTR( Smad7-3’UTR-Mut) of Smad7 were co-transfected into HEK293 T cells and dual luciferase reporter gene system was applied to test luciferase activity. Results: DNA sequencing showed that the sequences of the cloned regions were correct. The luciferase activity of Smad7-3’ UTR-WT plasmid treated with miRNA-195 was decreased to about 40% compared with control. The mutant 3’-UTR were no longer repressed by miRNA-195. Conclusion: The Smad7 3’-UTR luciferase reporter vector has been constructed successfully.MiRNA-195 can repress the luciferase activity of the reporter gene and had direct effect on Smad7 3’-UTR.
出处 《江苏大学学报(医学版)》 CAS 2015年第4期286-289,共4页 Journal of Jiangsu University:Medicine Edition
关键词 MicroRNA195 SMAD7基因 荧光素酶报告基因 3’-UTR MicroRNA195 Smad7 luciferase reporter gene 3’-UTR
  • 相关文献

参考文献9

  • 1王瑜,付洁,程龙,徐小洁,宋海峰,叶棋浓.靶向FHL1的microRNA初步筛选研究[J].军事医学,2013,37(6):423-426. 被引量:2
  • 2刁雪红,申锷,胡兵,张跃力,吴作辉,魏聪.糖尿病小鼠心肌组织microRNA表达谱分析[J].上海交通大学学报(医学版),2010,30(10):1194-1198. 被引量:9
  • 3李龙英,肖谦,高原,高爱滨,吴绮楠.SMAD3,SMAD7在糖尿病大鼠心肌组织的表达[J].中国老年学杂志,2009,29(2):132-134. 被引量:5
  • 4David P Bartel.MicroRNAs[J]. Cell . 2004 (2)
  • 5Massague J,Seoane J,Wotton D.Smad transcription factors. Genes and Development . 2005
  • 6Enright Anton J,John Bino,Gaul Ulrike,Tuschl Thomas,Sander Chris,Marks Debora S.MicroRNA targets in Drosophila. Genome Biology . 2004
  • 7Zhao Y,Samal E,Srivastava D.Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature . 2005
  • 8van Rooij Eva,Sutherland Lillian B,Liu Ning,Williams Andrew H,McAnally John,Gerard Robert D,Richardson James A,Olson Eric N.A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America . 2006
  • 9van Rooij E,Sutherland LB,Qi X,et al.Control of stress-dependent cardiac growth and gene expression by a microRNA. Science . 2007

二级参考文献35

  • 1王岚峰,张蕾,张瑞英,李少君.Smad表达与心肌梗死后心室重构的关系[J].中华心血管病杂志,2005,33(10):932-935. 被引量:12
  • 2苗雅,张薇,钟明,马骁,亓同刚,孙慧.糖尿病心肌病中转化生长因子β_1相关的Smads信号通路的激活及缬沙坦的干预作用[J].中华医学杂志,2007,87(6):366-370. 被引量:13
  • 3Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system [ J ]. Cardiovasc Res,2006 ; 69 ( 1 ) : 15-25.
  • 4Schneiders D, Heger J, Best P, et al. SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes [J]. Cardiovasc Res, 2006 ; 67( 1 ) : 187-96.
  • 5Hao J, Ju H, Zhao S, et al. Elevation of expression of Smads2,3 and 4, deeorin and TGF-beta in the chronie phase of myocardial infraet sear healing[J]. J Mol Cell Cardiol,1999 ;31:667-78.
  • 6Wang B, Omar A, Angelovska T, et al. Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts[J]. Am J Physoil Heart Circ Physiol,2007 ;293 ( 2 ) : H1282-90.
  • 7Azar ST, Sahi I, Zantout MS, et al. Aheration in plasma transforming growth factor beta in normoalbuinuric type 1 and type 2 diabetic patient [J]. J Clin Endoerinol Metab ,2002 ;85 (12) :4680-1.
  • 8Li JH, Huang XR, Zhu H J, et al. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and-independent mechamism: implications for diabetic renal and vascular disease [J]. FASEB J ,2004; 18(1) :176-8.
  • 9Rodriguez-Vita J, Sanchez-Lopez E, Esteban V, et al. Angiotensin II activates the smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism [J] . Circulation, 2005 ; 111 (19) :2509-17.
  • 10Asghar O,Al-Sunni A,Khavandi K,et al.Diabetic cardiomyopathy[J].Clin Sci (Lond),2009,116(10):741-760.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部